CRYPTIC TRANSCRIPTS: THE MASKED HEROES WHO BREAK TUMOR IMMUNE TOLERANCE AND FREE THE RESPONSE TO IMMUNE THERAPY.
Dual targeting of CCr2 and CCR5 as thearpy for hepatocellular carcinoma: can we break immune tolerance?
Food allergy after pediatric liver transplantation: role of the immature immune system and liver in oral tolerance
Induction of multiple sclerosis (MS)-specific immune toleration using tolerogene dendritic cells and regulatory T cells. Preclinical evaluation of the therapeutic potential of cellular immune therapy in MS.
The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces transgene-specific immune tolerance with low genotoxic risk
Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII-specific T cells